- Decrease of myelofibrosis after therapy 2-CdA in patients with hairy cell leukemiaPublication without faculty affiliation
- Long-term results of 2-CdA therapy in patients with hairy cell leukemia (HCL) +1Publication without faculty affiliation
- Hairy cell leukemia - diagnosis and therapy in 20072007 | Publication without faculty affiliation
- Hairy cell leukemia - diagnosis and therapy in 20072007 | Faculty of Medicine in Hradec Králové
- Hairy cell leukemia - diagnosis and therapy in 20072007 | First Faculty of Medicine
- Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML - Results from Study AML-BFM 20042015 | Second Faculty of Medicine
- Long term follow-up of MRD in patients with hairy cell leukemia in complete remission after the therapy with 2-CDAPublication without faculty affiliation
- Hairy cell leukemia and contribution of 2-chlorodeoxyadenosin in the treatment2006 | Publication without faculty affiliation
- Hairy cell leukemia and contribution of 2-chlorodeoxyadenosin in the treatment +12006 | Faculty of Medicine in Hradec Králové
- Hairy cell leukemia and contribution of 2-chlorodeoxyadenosin in the treatment2006 | First Faculty of Medicine
- Immunohistochemical detection of a residual leukemic population in the trephine bone marrow biopsy in patients with hairy cell leukemia after the therapy by 2-chlorodeoxyadenosine (2-CdA)Publication without faculty affiliation
- Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine2006 | Second Faculty of Medicine
- Dyserythropoietic changes and sideroblastic anemia in patients with hairy cell leukemia before and after therapy with 2-chlorodeoxyadenosine1998 | Faculty of Medicine in Hradec Králové
- Science Award Winner for Outstanding achievement in Clinical Pediatrics2015 | Second Faculty of Medicine